Different shapes of amyloid‑beta clumps in Alzheimer's

Structural and Biological Characterization of Diverse Oligomers Derived from Abeta

NIH-funded research University of California-Irvine · NIH-11371599

Researchers are making and comparing different small clumps of the amyloid‑beta protein to see how they affect brain cells in people with Alzheimer's disease.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California-Irvine NIH-funded
Lab location1 site (Irvine, United States)
Project IDNIH-11371599 on NIH RePORTER

What this research studies

If you or a loved one has Alzheimer's, this research makes precise lab versions of different amyloid‑beta clumps and uses high‑resolution methods to reveal their shapes. The team stabilizes those shapes so they can test how each one interacts with brain cells like neurons, microglia, and astrocytes. They then link the exact structure of each clump to how toxic or inflammatory it is. This lab work aims to explain which forms of amyloid‑beta are most harmful and why.

Who could benefit from this research

Good fit: People with Alzheimer's disease or individuals able to donate relevant biological samples (for example brain tissue, cerebrospinal fluid, or blood) would be most relevant to this work.

Not a fit: Patients seeking immediate treatment benefit are unlikely to gain direct clinical benefit because this is basic laboratory research into molecular mechanisms.

Why it matters

Potential benefit: If successful, the work could identify the specific amyloid‑beta structures that cause harm and guide development of better diagnostics or targeted therapies.

How similar studies have performed: Previous studies have linked amyloid‑beta oligomers to neuronal damage but their exact structures remain unclear, so creating stabilized, structurally defined models is a relatively novel approach.

Where this research is happening

Irvine, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.